Confined or spread disease-Spread into the peritoneum - Page 2 of 3 Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread into the peritoneum Posts on Medivizor

Can removal of the primary tumor improve survival outcomes in stage IV colorectal cancer?

Posted by on Jun 9, 2014 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate the impact of primary tumor removal and lymph node dissection on disease outcome in metastatic colorectal cancer.  Some background Approximately 15-20% of patients with colorectal cancer are diagnosed with distant metastasis (spread of the cancer) despite widespread screening. While in some...

Read More

New predictors of prognosis in colon cancer?

Posted by on Feb 18, 2014 in Colorectal cancer | 0 comments

In a nutshell The current study examined whether the proteins versican and lumican were predictive of prognosis among colon cancer patients. Some background Colon cancer treatments vary depending on the type and stage of the disease. Patients with advanced cancer, which has invaded the surrounding lymph nodes, usually receive chemotherapy along...

Read More

Overall survival gain with the addition of aflibercept to standard chemotherapy

Posted by on Jan 16, 2014 in Colorectal cancer | 0 comments

In a nutshell This study estimated survival gain with the addition of aflibercept (Zaltrap) to standard chemotherapy among patients with metastatic colorectal cancer. Some background A combination chemotherapy regimen referred to as FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) is considered the standard of care in the treatment of...

Read More

Combination of capecitabine and bevacizumab

Posted by on Jan 3, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the use of capecitabine in combination with bevacizumab (Avastin) in the treatment of unresectable metastatic colorectal cancer. Some background Current treatment of unresectable metastatic colorectal cancer (wide spread cancer that cannot be removed by surgery do to size or location) includes chemotherapy, such...

Read More

More risk with regorafenib

Posted by on Dec 6, 2013 in Colorectal cancer | 0 comments

In a nutshell This study examined whether there is an increased risk of hypertension among cancer patients being treated with regorafenib (Stivarga). Some background Vascular endothelial growth factor receptors (VEGF-r) are complexes on the surface of cells which stimulate the growth of new blood vessels, and are crucial for cancer growth and...

Read More

Evaluating the safety and efficacy of adding bevacizumab in two capecitabine-based chemotherapy regimens for the treatment of patients with metastatic colorectal cancer

Posted by on Jul 23, 2013 in Colorectal cancer | 0 comments

In a nutshell This phase II clinical trial investigated the addition of bevacizumab to two chemotherapy regimens for the first line treatment of patients with metastatic colorectal cancer (CRC). Some background Cancer cells need blood supply in order to grow. They do so by forming new blood vessels, thus feeding themselves. Bevacizumab (Avastin)...

Read More

Intermittent versus continuous chemotherapy in advanced colorectal cancer

Posted by on Jun 11, 2013 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to assess the effects of pauses during chemotherapy in patients with advanced colorectal cancer (CRC).  Some background In advanced CRC (cancer of the large bowel that has spread to the lymph nodes and other tissues and organs of the body) the cancer is more difficult to remove. Patients usually need...

Read More